Civil Plaintiff
Teva Pharmaceuticals Agrees to Pay Louisiana $15 Million to Settle Opioid Claims
Teva Pharmaceuticals, the US subsidiary of Israel’s Teva Pharmaceutical Industries, has reached an agreement with the attorney general of Louisiana to pay $15 million to settle the state’s opioid-related claims against the company and provide an additional donation of medicines that aid in opioid addiction and recovery, valued at $3 million.
The legal settlement was announced on Tuesday and finalization is contingent on confirmation from the state by November 2, Teva indicated in a statement. Teva’s shares were up 6 percent to $9.81 following the announcement.
Under the terms of the deal, Teva will pay the $15 million settlement over a period of 18 years.
